78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension.
作者信息
Bois John P, Valles Alfred G, Sinak Lawrence J
机构信息
Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN 55905, USA.
出版信息
Mayo Clin Proc. 2010 Nov;85(11):e78-81. doi: 10.4065/mcp.2010.0097.
Abstract
摘要
相似文献
1
78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension.78岁男性，患有转移性鳞状细胞癌、呼吸困难和低血压。
Mayo Clin Proc. 2010 Nov;85(11):e78-81. doi: 10.4065/mcp.2010.0097.
2
Occult carcinoma penis presenting as malignant pleural effusion.阴茎隐匿性癌表现为恶性胸腔积液。
Monaldi Arch Chest Dis. 2020 Oct 1;90(4). doi: 10.4081/monaldi.2020.1384.
3
Cytologic diagnosis of metastatic penile carcinoma in pleural effusion.
Arch Pathol Lab Med. 1992 Feb;116(2):198-9.
4
Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.初诊时恶性胸腔积液对转移性非小细胞肺癌患者预后的影响。
J Thorac Oncol. 2012 Oct;7(10):1485-9. doi: 10.1097/JTO.0b013e318267223a.
5
Squamous cell carcinoma of the lung in association with sarcoidosis.肺鳞状细胞癌合并结节病。
Asian Cardiovasc Thorac Ann. 2009 Jun;17(3):291-3. doi: 10.1177/0218492309104764.
6
Unusual pleural effusion from vulvar squamous cell carcinoma: report of a case and review of the literature.外阴鳞状细胞癌所致罕见胸腔积液：一例报告并文献复习
Pathologica. 2016 Sep;108(3):148-150.
7
Pleural effusion in lung cancer.肺癌中的胸腔积液
Clin Chest Med. 1993 Mar;14(1):189-200.
8
EGFR mutations in squamous cell lung cancer in never-smokers.从不吸烟者肺鳞状细胞癌中的表皮生长因子受体（EGFR）突变
J Thorac Oncol. 2013 Jan;8(1):e6-7. doi: 10.1097/JTO.0b013e3182762d49.
9
Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.一种简单的术中胸腔内热疗对伴有恶性胸腔积液或播散的肺癌的影响。
Interact Cardiovasc Thorac Surg. 2010 Apr;10(4):568-71. doi: 10.1510/icvts.2009.225110. Epub 2010 Jan 21.
10
Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.以恶性胸腔积液为表现的临床隐匿性原发性输卵管癌。
Clin Respir J. 2017 Nov;11(6):1086-1090. doi: 10.1111/crj.12423. Epub 2016 Jan 4.
本文引用的文献
1
Assessing risk of venous thromboembolism in the patient with cancer.评估癌症患者静脉血栓栓塞的风险。
J Clin Oncol. 2009 Oct 10;27(29):4839-47. doi: 10.1200/JCO.2009.22.3271. Epub 2009 Aug 31.
2
3
Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion.细胞学异常预示着心包积液癌症患者的预后不良。
J Clin Oncol. 2005 Aug 1;23(22):5211-6. doi: 10.1200/JCO.2005.00.745.
4
Secondary malignant tumors of the pericardium.心包继发性恶性肿瘤。
Circulation. 1962 Aug;26:228-41. doi: 10.1161/01.cir.26.2.228.
5
Acute cardiac tamponade.急性心脏压塞
N Engl J Med. 2003 Aug 14;349(7):684-90. doi: 10.1056/NEJMra022643.
6
Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years.连续1127例经超声心动图引导的心包穿刺术：21年的临床概况、实践模式及结果
Mayo Clin Proc. 2002 May;77(5):429-36. doi: 10.4065/77.5.429.
7
Role of biochemical tests in the diagnosis of large pericardial effusions.
Chest. 2002 Feb;121(2):495-9. doi: 10.1378/chest.121.2.495.
8
Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer.心包积液细胞学检查在非小细胞肺癌相关心脏压塞中的预后作用
Chest. 2000 Sep;118(3):744-9. doi: 10.1378/chest.118.3.744.
9
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.原发性非小细胞肺癌患者心包内注射卡铂控制恶性心包积液
Br J Cancer. 2000 Oct;83(7):858-62. doi: 10.1054/bjoc.2000.1397.
10
Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.恶性肿瘤患者心包积液的初次及二次治疗结果
Mayo Clin Proc. 2000 Mar;75(3):248-53. doi: 10.4065/75.3.248.
Zotero 插件